The interrelated epidemic of HPV and HIV in Kenya: Opportunities for health system integration and mobilisation towards a common goal

The global burden of cervical cancer is not spread equally.

Elevating health and wellbeing at a time of global uncertainty

Ahead of the World Health Summit 2022, David Humphreys﹘Economist Impact's global practice lead for health policy﹘and his team of policy experts, clinicians and specialists explore six important themes in healthcare.

Confronting the fragility of medicine supply chains

Confronting the fragility of medicine supply chains is an Economist Impact report, sponsored by LEO Pharma A/S. The white paper examines the complex causes of disruptions in the supply chains for drugs, with a particular focus on their active pharmaceutical ingredients (APIs). Disruption of supply chains was a common feature of the pandemic. Yet, the structural and economic circumstances that helped contribute to these problems were in existence well before covid-19 made its first appearance.

Corporations should use the pandemic to showcase science careers

Science, technology, engineering, and mathematics (STEM)corporate talent initiatives can be boosted from the momentum brought about by the covid-19 pandemic momentum.

The Future of Precision Medicine Oncology: Toward a New Post-Pandemic Normal

More than a dozen roundtable participants from different sides of the healthcare landscape came together to discuss what is needed to drive precision medicine oncology progress. In doing so, they explored fundamental obstacles that lie ahead for precision medicine innovation such as expanding genomic testing access, improving clinical trials and data collection, helping patients navigate complex testing and treatment journeys, and breaking down silos among stakeholders.

Navigating the Next Frontier of Precision Medicine Oncology

The covid-19 pandemic has exposed the vulnerabilities and inequities of the global healthcare system, but it could also catalyze overdue transformative change.

The world must devise a globally fair covid-19 vaccine allocation system

The head of the covid-19 vaccine response argues that US $2bn will be needed for eight potential vaccines to go through clinical trials.

Enabling people to manage their health and wellbeing: Policy approaches to self-care

About this report

Enabling people to manage their health and wellbeing:  Policy approaches to self-care is a report written by The Economist Intelligence Unit and sponsored by RB, a UK consumer goods company. The report considers the key elements and drivers for self-care, and examines the political and regulatory response across three global markets: the US, Europe and BRICS (Brazil, Russia, India, China and South Africa).

A misunderstood skin disease: Mapping the policy response to atopic dermatitis

Atopic dermatitis (AD), also known as eczema or atopic eczema (AE), is a common chronic inflammatory non-communicable skin disease that often manifests itself in flares of dry, red and itchy skin. It is not a well-understood disease. Lifetime prevalence can vary widely across the globe, ranging from 9% to 32%. 

For those without direct experience, it can be challenging to understand the lengths to which cracked, itchy skin can overwhelm a person’s quality of life, as well as affect the lives of their family and caregivers.

医疗保健的未来:预防性、个性化及精准化

富有和经常全球旅行的人的医疗习惯可以为先进医疗科技融入人们生活的方式提供范例,也可能为科技在未来的广泛采用做下铺垫。为探究这种现象,经济学人智库(The Economist Intelligence Unit/EIU)调查了亚洲、中东及非洲快速发展地区的480位高净值人士(high-net-worth individuals, HNWIs),以探究他们现在的医疗习惯可能会如何推动社会整体上的突破。

数据显示,医疗保健的未来将更加具有预防性、个性化以及精准。同时未来也将不那么专注于治疗,而是更多关注定制个性化生活方式,改变生活习惯以管理个人健康风险、预防疾病。

很多现在的创新都在稳步地推动着这种改变。新的科技正在以前所未有的规模生产着生物特征数据,手机应用、基因检测以及先进的筛查技术只是其中的一部分。大数据分析和人工智能(artificial intelligence, AI)正在运用大量的信息为医护人员及患者提供更深入的分析洞察,以帮助他们更好地设定健康目标及衡量进展。当罹患疾病时,精准医疗、免疫学以及 3D 打印技术方面的突破也为更加个性化的治疗创造了可能。

然而,当医疗科技从有限的运用领域中走向普罗大众时,它们的效用及潜力可能会受到遗留系统、道德争议以及实用性方面的阻碍。

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week